Etelcalcetide in Patients on Hemodialysis with Severe Secondary Hyperparathyroidism. Multicenter Study in “Real Life”

Etelcalcetide is a new calcimimetic indicated for the treatment of secondary hyperparathyroidism (SHPT) in dialysis patients. Etelcalcetide efficacy in SHPT has been ascertained only in randomized controlled trials. This multicenter study was carried out in “real world” setting that is different fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Russo, Domenico, Tripepi, Rocco, Malberti, Fabio, Di Iorio, Biagio, Scognamiglio, Bernadette, Di Lullo, Luca, Paduano, Immacolata Gaia, Tripepi, Giovanni Luigi, Panuccio, Vincenzo Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678718/
https://www.ncbi.nlm.nih.gov/pubmed/31330805
http://dx.doi.org/10.3390/jcm8071066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678718/
https://www.ncbi.nlm.nih.gov/pubmed/31330805
http://dx.doi.org/10.3390/jcm8071066

Ejemplares similares